LPL Financial
CRMD icon

LPL Financial’s CorMedix CRMD Stock Holding History

LPL Financial’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
138,166
-6,774
-5% -$53.5K ﹤0.01% 4360
2026
Q1 		$984K Sell
144,940
-84,496
-37% -$625K ﹤0.01% 4191
2025
Q4 		$2.67M Sell
229,436
-91,290
-28% -$1.01M ﹤0.01% 3125
2025
Q3 		$3.73M Buy
320,726
+237,896
+287% +$2.88M ﹤0.01% 2736
2025
Q2 		$1.02M Buy
82,830
+22,263
+37% +$246K ﹤0.01% 3741
2025
Q1 		$373K Buy
60,567
+7,000
+13% +$72.5K ﹤0.01% 4419
2024
Q4 		$434K Sell
53,567
-3,198
-6% -$31.9K ﹤0.01% 4215
2024
Q3 		$459K Buy
56,765
+8,687
+18% +$47K ﹤0.01% 4067
2024
Q2 		$208K Sell
48,078
-4,322
-8% -$22K ﹤0.01% 4541
2024
Q1 		$222K Buy
52,400
+30,600
+140% +$106K ﹤0.01% 4433
2023
Q4 		$82K Buy
21,800
+1,000
+5% +$3.44K ﹤0.01% 4583
2023
Q3 		$77K Buy
20,800
+800
+4% +$3.18K ﹤0.01% 4464
2023
Q2 		$79.3K Hold
20,000
– – ﹤0.01% 4364
2023
Q1 		$82.8K Hold
20,000
– – ﹤0.01% 4240
2022
Q4 		$84.4K Sell
20,000
-9,303
-32% -$32.9K ﹤0.01% 4205
2022
Q3 		$83K Buy
29,303
+16,980
+138% +$70.6K ﹤0.01% 4149
2022
Q2 		$50K Hold
12,323
– – ﹤0.01% 4233
2022
Q1 		$68K Buy
+12,323
New +$56.4K ﹤0.01% 4024
2021
Q1 		– Sell
-17,630
Closed -$131K – 4095
2020
Q4 		$131K Sell
17,630
-657
-4% -$4.47K ﹤0.01% 3636
2020
Q3 		$110K Buy
18,287
+4,550
+33% +$22.9K ﹤0.01% 3348
2020
Q2 		$87K Buy
+13,737
New +$63.6K ﹤0.01% 3308

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

LPL Financial's CRMD Position: Q2 2026 in Review

LPL Financial reduced its CorMedix (CRMD) stake by 4.7% in Q2 2026, selling an estimated $53.5K and leaving 138,166 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

LPL Financial first reported a position in CRMD in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.73M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • LPL Financial held 138,166 shares of CorMedix worth $1.08M as of Q2 2026.
  • LPL Financial sold 6,774 CorMedix shares in Q2 2026, an estimated $53.5K.
  • CorMedix made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4360 holding.
  • LPL Financial first reported a position in CorMedix in Q2 2020 and has held it in 21 quarters since.
  • LPL Financial's CorMedix position peaked at $3.73M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.